Sofinnova Investments, Inc.

13D and 13G Filings

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Schedule 13G · 1 security · passive
Marinus Pharmaceuticals, Inc. 13G/A MRNS · 56854Q200	MRNS	56854Q200	0%	0	13G/A	2/12/2025 Event 12/31/2024
Sofinnova Investments, Inc.			0%	0
Sofinnova BioEquities GP LLC			0%	0
James Healy			0%	0
Eric Delbridge			0%	0

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.